Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8.
Novel mRNA isoforms for two members of the group III metabotropic glutamate receptors (mGluRs), called mGluR7b and mGluR8b, were identified from rat brain cerebral cortex and hippocampus. In both cases, the alternative splicing is generated by a similar out-of-frame insertion in the carboxyl-terminus that results in the replacement of the last 16 amino acids of mGluR7 and mGluR8 by 23 and 16 different amino acids, respectively. Distribution analysis for mGluR7 and mGluR8 isoforms revealed that the two splice variants are generally coexpressed in the same brain areas. The few exceptions were the olfactory bulb, in which only the mGluR7a form could be detected by reverse transcription-polymerase chain reaction, and the lateral reticular and ambiguous nuclei, which showed only mGluR8a labelling. Despite expression in the same regions, different mRNA abundance for the two variants of each receptor were observed. When transiently coexpressed in HEK 293 cells with the phospholipase C-activating chimeric G alpha qi9-G-protein, the a and b forms for both receptor subtypes showed a similar pharmacological profile. The rank order of potencies for both was: DL-amino-4-phosphonobutyrate > L-serine-O-phosphate > glutamate. However, the agonist potencies were significantly higher for mGluR8a, b compared with mGluR7a,b. In Xenopus oocytes, glutamate evoked currents only with mGluR8 when coexpressed with Kir 3.1 and 3.4. Glutamate-induced currents were antagonized by the group II/III antagonist (RS)-alpha-cyclopropyl-4-phosphonophenylglycine. In conclusion, the two isoforms of each receptor have identical pharmacological profiles when expressed in heterologous systems, despite structural differences in the carboxyl-terminal domains.
Corti
C
C
Department of Pharmacology, GlaxoWellcome Medicines Research Centre, Verona, Italy.
Restituito
S
S
Rimland
J M
JM
Brabet
I
I
Corsi
M
M
Pin
J P
JP
Ferraguti
F
F
D017398:Alternative Splicing / Q000502:physiology*; D000818:Animals; D016375:Antisense Elements (Genetics); D001483:Base Sequence; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000737:chemistry; D003001:Cloning, Molecular; D017931:DNA Primers; D004594:Electrophysiology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels; D018698:Glutamic Acid / Q000494:pharmacology; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D006624:Hippocampus / Q000737:chemistry; D006801:Humans; D007295:Inositol Phosphates / Q000032:analysis; D007668:Kidney / Q000166:cytology; D008564:Membrane Potentials / Q000187:drug effects; D008969:Molecular Sequence Data; D009865:Oocytes / Q000502:physiology; D015221:Potassium Channels / Q000502:physiology; D024661:Potassium Channels, Inwardly Rectifying; D011422:Propionates / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis*; D051381:Rats; D018094:Receptors, Metabotropic Glutamate / Q000235:genetics*; D017386:Sequence Homology, Amino Acid; D014981:Xenopus
C114785:2-amino-4-phosphono-propinate; D016375:Antisense Elements (Genetics); D017931:DNA Primers; D018691:Excitatory Amino Acid Antagonists; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels; D007295:Inositol Phosphates; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D011422:Propionates; D012333:RNA, Messenger; D018094:Receptors, Metabotropic Glutamate; C104331:cyclopropyl-4-phosphonophenylglycine; C102719:metabotropic glutamate receptor 7; C111435:metabotropic glutamate receptor 8; D018698:Glutamic Acid; D005998:Glycine